Paper34459110
Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling.
Chen Q and 6 others. J Cell Mol Med, 2021. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling. Papers, record 34459110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34459110
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Cell Cycle Proteins | Major topic |
| Cytoskeletal Proteins | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Synovial Membrane | Major topic |
| Transcription Factors | Major topic |
| Aged | |
| Aged, 80 and over | |
| Animals | |
| Biomarkers | |
| Cell Line | |
| Cells, Cultured | |
| Disease Models, Animal | |
| Disease Progression | |
| Disease Susceptibility | |
| Female | |
| Gene Expression | |
| Humans | |
| Immunohistochemistry | |
| Male | |
| Mice | |
| Middle Aged | |
| Neovascularization, Pathologic | |
| Severity of Illness Index | |
| Signal Transduction | |
| Ezrin |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 38015078 | Correction to Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling. | https://conductscience.org/library/papers/38015078 |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14704791 | The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. | Nat Med | 2004 | https://conductscience.org/library/papers/14704791 | PubMed |
| 2 | 28002618 | Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex. | Cancer Sci | 2017 | https://conductscience.org/library/papers/28002618 | PubMed |
| 3 | 28643776 | Ezrin enhances line tension along transcellular tunnel edges via NMIIa driven actomyosin cable formation. | Nat Commun | 2017 | https://conductscience.org/library/papers/28643776 | PubMed |
| 4 | 25487920 | The regulation and function of YAP transcription co-activator. | Acta Biochim Biophys Sin (Shanghai) | 2015 | https://conductscience.org/library/papers/25487920 | PubMed |
| 5 | 12802084 | Ezrin regulates E-cadherin-dependent adherens junction assembly through Rac1 activation. | Mol Biol Cell | 2003 | https://conductscience.org/library/papers/12802084 | PubMed |
| 6 | 3358796 | The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. | Arthritis Rheum | 1988 | https://conductscience.org/library/papers/3358796 | PubMed |
| 7 | 24837142 | The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation. | Exp Eye Res | 2014 | https://conductscience.org/library/papers/24837142 | PubMed |
| 8 | 27072970 | Knockdown of ezrin suppresses the migration and angiogenesis of human umbilical vein endothelial cells in vitro. | J Huazhong Univ Sci Technolog Med Sci | 2016 | https://conductscience.org/library/papers/27072970 | PubMed |
| 9 | 20851025 | Blood vessels, a potential therapeutic target in rheumatoid arthritis? | Joint Bone Spine | 2011 | https://conductscience.org/library/papers/20851025 | PubMed |
| 10 | 19234525 | YAP, TAZ, and Yorkie: a conserved family of signal-responsive transcriptional coregulators in animal development and human disease. | Biochem Cell Biol | 2009 | https://conductscience.org/library/papers/19234525 | PubMed |
| 11 | 24478334 | Deletion of yes-associated protein (YAP) specifically in cardiac and vascular smooth muscle cells reveals a crucial role for YAP in mouse cardiovascular development. | Circ Res | 2014 | https://conductscience.org/library/papers/24478334 | PubMed |
| 12 | 24550173 | The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. | Ann Rheum Dis | 2014 | https://conductscience.org/library/papers/24550173 | PubMed |
| 13 | 29853727 | Cartilage and bone damage in rheumatoid arthritis. | Reumatologia | 2018 | https://conductscience.org/library/papers/29853727 | PubMed |
| 14 | 29884210 | Pannus inflammation in sacroiliitis following immune pathological injury and radiological structural damage: a study of 193 patients with spondyloarthritis. | Arthritis Res Ther | 2018 | https://conductscience.org/library/papers/29884210 | PubMed |
| 15 | 14676203 | Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin. | J Biol Chem | 2004 | https://conductscience.org/library/papers/14676203 | PubMed |
| 16 | 19234486 | Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration. | Oncogene | 2009 | https://conductscience.org/library/papers/19234486 | PubMed |
| 17 | 10462524 | Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin. | J Cell Sci | 1999 | https://conductscience.org/library/papers/10462524 | PubMed |
| 18 | 29417936 | Rheumatoid arthritis. | Nat Rev Dis Primers | 2018 | https://conductscience.org/library/papers/29417936 | PubMed |
| 19 | 28754689 | Ezrin directly interacts with AQP2 and promotes its endocytosis. | J Cell Sci | 2017 | https://conductscience.org/library/papers/28754689 | PubMed |
| 20 | 26045258 | YAP and TAZ: a nexus for Hippo signaling and beyond. | Trends Cell Biol | 2015 | https://conductscience.org/library/papers/26045258 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42865714 | Sanguinarine ameliorates rheumatoid arthritis by activating the Hippo-YAP/TAZ pathway to induce apoptosis and suppress inflammation in fibroblast-like synoviocytes. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42865714 | PubMed |
| 41599830 | Therapeutic Effect and Underlying Mechanism of Blue Mussel (Mytilus galloprovincialis) Oil on Adjuvant-Induced Rheumatoid Arthritis in Rats. | Nutrients | 2026 | https://conductscience.org/library/papers/41599830 | PubMed |
| 40986234 | Kaempferol-A Natural Drug for Rheumatoid Arthritis. | Chin J Integr Med | 2025 | https://conductscience.org/library/papers/40986234 | PubMed |
| 40955298 | Angiotensin-(1-7) Inhibits Angiogenesis and Alleviates Joint Damage in CIA Mice via the Hippo-YAP Pathway. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/40955298 | PubMed |
| 40292098 | The Hippo pathway in bone and cartilage: implications for development and disease. | PeerJ | 2025 | https://conductscience.org/library/papers/40292098 | PubMed |
| 40255565 | The emerging role of vascular endothelial cell-mediated angiogenesis in the imbalance of RA synovial microenvironment and its clinical relevance. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40255565 | PubMed |
| 38899353 | Research progress on Hippo signaling pathway effector molecules in rheumatic immune system diseases. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2024 | https://conductscience.org/library/papers/38899353 | PubMed |
| 38533025 | Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis. | Heliyon | 2024 | https://conductscience.org/library/papers/38533025 | PubMed |
| 38486990 | GRK2 mediated degradation of SAV1 initiates hyperplasia of fibroblast-like synoviocytes in rheumatoid arthritis. | Acta Pharm Sin B | 2024 | https://conductscience.org/library/papers/38486990 | PubMed |
| 38406325 | The Hippo-YAP Signaling Pathway in Osteoarthritis and Rheumatoid Arthritis. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/38406325 | PubMed |
| 38015078 | Correction to Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling. | J Cell Mol Med | 2023 | https://conductscience.org/library/papers/38015078 | PubMed |
| 37809969 | Carboxyamidotriazole alleviates pannus formation and cartilage erosion in rats with adjuvant arthritis. | Heliyon | 2023 | https://conductscience.org/library/papers/37809969 | PubMed |
| 37791063 | Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway. | Open Life Sci | 2023 | https://conductscience.org/library/papers/37791063 | PubMed |
| 37715217 | Coix seed oil alleviates synovial angiogenesis through suppressing HIF-1α/VEGF-A signaling pathways via SIRT1 in collagen-induced arthritis rats. | Chin Med | 2023 | https://conductscience.org/library/papers/37715217 | PubMed |
| 36444960 | Actin cytoskeleton in angiogenesis. | Biol Open | 2022 | https://conductscience.org/library/papers/36444960 | PubMed |
| 36421382 | Stk10 Deficiency in Mice Promotes Tumor Growth by Dysregulating the Tumor Microenvironment. | Biology (Basel) | 2022 | https://conductscience.org/library/papers/36421382 | PubMed |
| 35806074 | Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806074 | PubMed |
| 34844926 | Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis. | Ann Rheum Dis | 2022 | https://conductscience.org/library/papers/34844926 | PubMed |
| 34459110 | Ezrin regulates synovial angiogenesis in rheumatoid arthritis through YAP and Akt signalling. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/34459110 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CDH5 | 1003 | PubTator's text mining | https://conductscience.org/library/genes/1003 | NCBI Gene |
| EZR | 7430 | PubTator's text mining | https://conductscience.org/library/genes/7430 | NCBI Gene |
| MSN | 4478 | PubTator's text mining | https://conductscience.org/library/genes/4478 | NCBI Gene |
| PECAM1 | 5175 | PubTator's text mining | https://conductscience.org/library/genes/5175 | NCBI Gene |
| RDX | 5962 | PubTator's text mining | https://conductscience.org/library/genes/5962 | NCBI Gene |
| YAP1 | 10413 | PubTator's text mining | https://conductscience.org/library/genes/10413 | NCBI Gene |
| YY1AP1 | 55249 | PubTator's text mining | https://conductscience.org/library/genes/55249 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34459110
GET https://conductscience.org/api/papers/v1/34459110/references?page=2